Last reviewed · How we verify
Determination of ESR1 mutations — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Determination of ESR1 mutations (Determination of ESR1 mutations) — Centre Henri Becquerel.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Determination of ESR1 mutations TARGET | Determination of ESR1 mutations | Centre Henri Becquerel | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Determination of ESR1 mutations CI watch — RSS
- Determination of ESR1 mutations CI watch — Atom
- Determination of ESR1 mutations CI watch — JSON
- Determination of ESR1 mutations alone — RSS
Cite this brief
Drug Landscape (2026). Determination of ESR1 mutations — Competitive Intelligence Brief. https://druglandscape.com/ci/determination-of-esr1-mutations. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab